CervoMed Inc. Fair Value of Assets Acquired
CervoMed Inc. (CRVO) reported Fair Value of Assets Acquired of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2018-04-02
- CervoMed Inc. fair value of assets acquired for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. fair value of assets acquired for the quarter ending 2016-12-31 was $0.00.
- CervoMed Inc. fair value of assets acquired for the quarter ending 2016-09-30 was $0.00.
- CervoMed Inc. fair value of assets acquired for the quarter ending 2016-06-30 was $0.00.
- CervoMed Inc. fair value of assets acquired for fiscal 2016 was $21.26M.
- CervoMed Inc. fair value of assets acquired for fiscal 2015 was $0.00.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 derived: sum of 3 quarters · filed 2018-04-02 | $0.00 derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 derived: sum of 3 quarters · filed 2018-04-02 | $21.26M 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | $21.26M 10-Q · filed 2017-11-13 | $21.26M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $21.26M 10-Q · filed 2017-08-14 | $21.26M derived: sum of 3 quarters · filed 2017-08-14 | $21.26M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $21.26M 10-Q · filed 2017-05-15 | $21.26M derived: sum of 2 quarters · filed 2017-05-15 | $21.26M derived: sum of 3 quarters · filed 2017-05-15 | $21.26M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |